1. Home
  2. CLRB vs PWM Comparison

CLRB vs PWM Comparison

Compare CLRB & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • PWM
  • Stock Information
  • Founded
  • CLRB 2002
  • PWM 2018
  • Country
  • CLRB United States
  • PWM Hong Kong
  • Employees
  • CLRB N/A
  • PWM N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • PWM
  • Sector
  • CLRB Health Care
  • PWM
  • Exchange
  • CLRB Nasdaq
  • PWM Nasdaq
  • Market Cap
  • CLRB 12.5M
  • PWM 13.3M
  • IPO Year
  • CLRB N/A
  • PWM 2023
  • Fundamental
  • Price
  • CLRB $0.36
  • PWM $0.40
  • Analyst Decision
  • CLRB Hold
  • PWM
  • Analyst Count
  • CLRB 2
  • PWM 0
  • Target Price
  • CLRB N/A
  • PWM N/A
  • AVG Volume (30 Days)
  • CLRB 34.3M
  • PWM 84.3K
  • Earning Date
  • CLRB 05-13-2025
  • PWM 06-17-2025
  • Dividend Yield
  • CLRB N/A
  • PWM N/A
  • EPS Growth
  • CLRB N/A
  • PWM N/A
  • EPS
  • CLRB N/A
  • PWM N/A
  • Revenue
  • CLRB N/A
  • PWM $639,912.00
  • Revenue This Year
  • CLRB N/A
  • PWM N/A
  • Revenue Next Year
  • CLRB N/A
  • PWM N/A
  • P/E Ratio
  • CLRB N/A
  • PWM N/A
  • Revenue Growth
  • CLRB N/A
  • PWM N/A
  • 52 Week Low
  • CLRB $0.22
  • PWM $0.31
  • 52 Week High
  • CLRB $3.42
  • PWM $2.70
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 61.13
  • PWM 47.64
  • Support Level
  • CLRB $0.23
  • PWM $0.34
  • Resistance Level
  • CLRB $0.69
  • PWM $0.43
  • Average True Range (ATR)
  • CLRB 0.05
  • PWM 0.04
  • MACD
  • CLRB 0.02
  • PWM -0.00
  • Stochastic Oscillator
  • CLRB 26.84
  • PWM 36.59

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About PWM Prestige Wealth Inc.

Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.

Share on Social Networks: